Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 6/20 | 0.52 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.52 |
| ▸ | IKZF2 | Q9UKS7 | 12/20 | 0.50 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.49 |
| ▸ | SALL4 | Q9UJQ4 | 1/20 | 0.49 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31737012 | 1.00 | CRBN (0.52) | CRBNDDB1IKZF2CSNK1A1SALL4 | |
| SCHEMBL31736810 | 1.00 | CRBN (0.52) | CRBNDDB1IKZF2CSNK1A1SALL4 | |
| SCHEMBL21340261 | 0.91 | CRBN (0.52) | CRBNDDB1IKZF2CSNK1A1SALL4 | |
| SCHEMBL31157996 | 0.90 | IKZF2 (0.56) | CRBNDDB1IKZF2CSNK1A1SALL4 | |
| SCHEMBL20046085 | 0.87 | IKZF2 (0.63) | CRBNDDB1IKZF2IKZF1 | |
| SCHEMBL29583366 | 0.87 | IKZF2 (0.63) | CRBNDDB1IKZF2IKZF1 | |
| SCHEMBL28895861 | 0.86 | CRBN (0.53) | CRBNDDB1IKZF2CSNK1A1SALL4 | |
| SCHEMBL31091727 | 0.86 | CRBN (0.54) | CRBNDDB1SALL4 | |
| SCHEMBL31736792 | 0.85 | IKZF2 (0.59) | CRBNDDB1IKZF2IKZF1 | |
| SCHEMBL31736849 | 0.85 | IKZF2 (0.59) | CRBNDDB1IKZF2IKZF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245178-A1 | PAK4, CSTF2, OR CSTF2T PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | INNOVO THERAPEUTICS, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| WO-2024233838-A1 | METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION | RANOK THERAPEUTICS (HANGZHOU) CO. LTD. (CN) | 2024-11-14 | — | — | WO | disclosed |